Vida’s clinical obesity program offers qualitative and quantitative results, with and without GLP-1s, but many are unaware of how those outcomes are driven, and how they can see success through Vida’s solutions.
Vida’s clinical obesity program offers qualitative and quantitative results, with and without GLP-1s, but many are unaware of how those outcomes are driven, and how they can see success through Vida’s solutions.
Obesity isn’t a willpower problem, and it never was.
Obesity is a growing health concern and many still face significant barriers to accessing obesity care. Employers who invest in providing obesity care can foster a healthier, more engaged workforce, while reducing healthcare costs.
Join Dr. Fatima Cody Stanford, Dr. Richard Frank, and Veeneta Lakhani as they break down what toda’ys evolving treatment landscape means for benefit leaders, payers, and consultants.